First, the cholesterol-induced disruption of CAV1-mediated lipid rafts (evidenced by SM(d18:2/16:0) accumulation) provides a molecular basis for altered signaling fidelity in hypercholesterolemia. This evidence concerns the gene CAV1 and Hypercholesterolemia.